{
}
Alto Neuroscience's experimental depression drug, ALTO-100, failed to show significant improvement over a placebo in a recent trial, leading to a two-thirds drop in the company's share price. Despite this setback, analysts maintain that the company's biomarker-driven approach to drug development still holds promise, with additional data expected from other studies by 2027. Alto has sufficient funds to continue operations and explore other therapeutic avenues.
Wave Life Sciences has reported promising early results from its RNA editing treatment for alpha-1 antitrypsin deficiency (AATD), showing significant increases in AAT protein levels in two patients. This marks a milestone in therapeutic RNA editing, with no serious side effects observed. The findings have boosted investor confidence, leading to a 75% rise in Wave's shares, while GSK prepares to take over development under their partnership.
Myles Minter
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
alto neuroscience faces setbacks as depression drug fails clinical trial
Stifel Financial Corp.
Rapport Therapeutics, Inc.
Neumora Therapeutics, Inc.
Nido Biosciences
Arch Venture Partners
Alto Neuroscience, Inc.
Amgen Inc.
William Blair CLS Ltd.
USA
Amit Etkin
Myles Minter
Paul Matties
Adam Savitz
Show more
18:03 23.10.2024
wave life sciences reports promising early results in rna editing trial
United States Dollar
Wave Life Sciences Ltd.
Takeda Pharmaceuticals
Proqraft B.V.
GSK plc
Korro Bio, Inc.
GBR
USA
JPN
Joseph Schwartz
Myles Minter
Paul Bolno
Show more
14:15 16.10.2024
Trending
Subcategory
Corporate News
Industry Trends
Startups & Entrepreneurship
Global Trade Developments
Stock Market Updates
Supply Chain Management
Industry Mergers & Acquisitions
Retail and Consumer Goods
Fintech Startups
Private Equity Deals
Government Economic Policies
Venture Capital Investments
Inflation and Monetary Impact
CEO Changes
Central Bank Actions
Workplace Trends
Energy Sector Developments
Corporate Social Responsibility
Economic Indicators
Emerging Startups
Countries:
Companies:
Apple Inc.
Google Inc.
Grab2Go AS
OLA ELECTRIC MOBILITY LTD
EFG Hermes Egypt
Li Auto Inc.
NIO Inc.
Delhivery Limited
Ecom Express Ltd.
Tesla, Inc.
XPeng Inc.
Morgan Stanley
Nikkei 225
Nintendo Co., Ltd.
Goto Ltd
Volkswagen AG
Mizuho Financial Group, Inc.
Mitsubishi UFJ Financial Group, Inc.
Microsoft Corporation
CATLOKI USD
Currencies:
United States Dollar
Indian Rupee
Euro
Chinese Yuan
Japanese Yen
United Arab Emirates Dirham
Egyptian Pound
South Korean Won
Pakistani Rupee
Indonesian Rupiah
Saudi Riyal
Offshore Chinese Yuan
Hong Kong Dollar
New Taiwan Dollar
Qatari Riyal
Malaysian Ringgit
Filipino Peso
West African CFA Franc
Thai Baht
Mexican Peso
People: